Akoya (AKYA) Misses Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Akoya Biosciences Inc (AKYA) PT Lowered to $3.50 at Canaccord Genuity
November 15, 2024 6:22 AM ESTCanaccord Genuity analyst Kyle Mikson lowered the price target on Akoya Biosciences Inc (NASDAQ: AKYA) to $3.50 (from $6.00) while maintaining a Buy rating.
The analyst comments "We reiterate our BUY rating on Akoya Biosciences (AKYA) shares and decrease our price target to $3.50 from $6. Although... More
